0
฿0.00
An empty cart
You have no item in your shopping cart
Product Category · Pharmaceutical IndustryPharmaceutical
Pharmaceutical
Dust CollectorAPI Containment &
GMP Dust Control
Pharmaceutical powder handling processes can generate airborne dust that affects product quality, operator safety, and process reliability. In facilities handling potent or combustible compounds, dust control systems must also support containment and explosion protection requirements. Our pharmaceutical dust collection systems are designed to capture dust at the source, support contamination control, and comply with GMP and ATEX safety requirements where applicable. Each system is specified according to the compound’s Occupational Exposure Band (OEB) classification and process conditions.
✓ HEPA H14 Filtration ✓ OEB 1–5 Classified ✓ ATEX Rated ✓ IQ/OQ Documentation
System Overview
Key Specifications
FiltrationHEPA H14 — ≥99.995% efficiency at 0.3 µm
ContainmentOEB 1–5 classified — source capture to isolator
ATEXZone 20/21/22 rated — combustible dust environments
DischargeSafe-change filter system — operator protection
ComplianceEU GMP, FDA 21 CFR, WHO GMP, ISPE
QualificationIQ/OQ documentation package — VMP aligned
✓ HEPA H14 ≥99.995% ✓ OEB 1–5 Classified ✓ ATEX Zone 20/21/22 ✓ Safe-Change Filter ✓ IQ/OQ Documentation
Industry Overview
Why Pharmaceutical Powder Dust Control Is a Dual GMP & Occupational Safety Obligation
In pharmaceutical manufacturing, airborne dust is not only a product contamination risk — it is an occupational health hazard with legal and regulatory consequences that go well beyond GMP compliance. Pharmaceutical Manufacturing Dust Control must address two distinct obligations simultaneously: protecting the product from cross-contamination by other compounds' powder, and protecting the operator from exposure to pharmacologically active airborne dust. EU GMP Chapter 3 and EMA guidelines on dedicated manufacturing require that potent compounds be handled with containment measures appropriate to their Occupational Exposure Band (OEB) classification — and the Pharmaceutical Dust Collector at each source is the primary engineering control that delivers that containment.
A Pharma Dust Extraction System for pharmaceutical manufacturing is fundamentally different from an industrial dust collector in its design requirements. Pharmaceutical dust collectors must use HEPA or ULPA filtration to retain captured powder within the unit rather than emitting it to atmosphere. The filter change-out procedure must be safe-change — meaning operators cannot be exposed to captured potent compounds during filter replacement. The system must be cleanable and free of dead zones that accumulate product between batches, and for many OSD (Oral Solid Dosage) manufacturing environments, must be ATEX-rated for combustible dust.
Our Pharmaceutical Powder Containment and Pharmaceutical Dust Filtration System solutions are specified to each compound's OEB classification — from standard pharmaceutical grade dust collectors for OEB 1–2 granulation and tablet compression areas through to fully contained high-potency API Powder Dust Collection systems for OEB 4–5 cytotoxic compound handling, with complete IQ/OQ qualification documentation.
- HEPA H14 filtration — ≥99.995% efficiency, retains powder within the collector unit
- OEB 1–5 containment classification — system specified to compound potency
- Safe-change filter system — operators never exposed to captured potent powder
- ATEX Zone 20/21/22 rated — compliant with combustible dust regulations
- GMP cleanable design — no dead zones, smooth internal surfaces, easy disassembly
- IQ/OQ documentation — performance verification including containment leakage test
Why It Matters
Three Critical Reasons Pharmaceutical Dust Collection Must Be Engineered for GMP & Safety
01🫁Operator Health & OEL Compliance
Pharmacologically Active Airborne Dust Is an Occupational Health Hazard Requiring Engineering Control
Pharmaceutical powders — unlike food or industrial dusts — are pharmacologically active at microgram-per-cubic-metre concentrations. An operator breathing air containing an anticoagulant compound at concentrations that appear visually invisible can receive a significant pharmacological dose within a single work shift. Occupational Exposure Limits (OELs) for potent pharmaceutical compounds are set in the microgram-per-cubic-metre range — 1,000 to 10,000 times lower than typical industrial dust OELs. The Pharma Dust Extraction System providing source capture at the process equipment is the primary engineering control for meeting these OELs — and is a legal obligation under national occupational health law as well as a GMP requirement.
ISPE Good Practice Guide on Assessing the Particulate Containment Performance of Pharmaceutical Equipment defines the OEB classification system used to match containment solutions to compound potency. Regulatory authorities increasingly inspect for documented OEB-to-containment mapping as part of GMP facility qualification.
02💥Combustible Dust & ATEX
Most Pharmaceutical Powders Are Combustible — ATEX Classification Is Mandatory
The majority of pharmaceutical active ingredients and excipients are combustible dusts — capable of propagating a dust explosion when suspended in air at sufficient concentration with an ignition source. Under ATEX Directive 2014/34/EU and NFPA 652, pharmaceutical manufacturers are legally required to classify their processing areas as dust hazard zones (Zone 20, 21 or 22) and specify dust collection equipment rated for that zone. A standard industrial Cleanroom Dust Collection System without ATEX certification is not legally permitted in a Zone 21 pharmaceutical processing area — regardless of how effective it may be at capturing powder. The consequences of a dust explosion in a pharmaceutical granulation or tablet compression area include catastrophic facility damage, operator casualties, and criminal liability for operators and management.
ATEX Zone 20 classification applies inside the dust collector housing where a continuous explosive dust cloud is present. Zone 21 applies in the immediate vicinity of charging ports, hoppers and transfer points. Zone 22 applies in the wider processing area where occasional explosive clouds may occur. Each zone requires equipment certified to a specific Ex category under ATEX.
03🔄Cross-Contamination Prevention
Pharmaceutical Dust Collectors Must Be Cleanable to GMP Standards Between Products
In multi-product pharmaceutical manufacturing facilities, the Pharmaceutical Process Dust Collector must be cleanable — or replaceable — between different product runs to prevent cross-contamination. A dust collector that cannot be thoroughly cleaned to validated residual limits between products becomes a route of cross-contamination that can result in incorrect active ingredients appearing in finished drug products. EU GMP Chapter 5 requires documented cleaning validation for all product-contact equipment — and a dust collector, whose internal surfaces directly contact aerosolised drug substance during operation, is product-contact equipment. Dedicated dust collectors per product, or cleanable units with validated cleaning procedures and swab sampling, are both acceptable strategies — but the decision must be risk-assessed and documented.
EMA Guideline on Setting Health-Based Exposure Limits (HBEL) for use in risk identification when manufacturing different medicinal products in shared facilities directly applies to dust collection equipment — the acceptable residual limit for the previous product on the next product's collector surfaces must be calculated and demonstrated through cleaning validation.
Product Range
GMP Pharmaceutical Dust Collector Systems — OEB 1 to OEB 5
Our Pharmaceutical Process Dust Collector range covers all OEB containment levels — from standard cartridge filter systems for non-potent solid dose manufacturing through to fully contained HEPA safe-change systems for high-potency API Powder Dust Collection applications.
⭐ OEB 1–2 Standard GMP 💊
Pharma Cartridge / Bag Filter Dust Collector
GMP pharmaceutical dust collector for non-potent solid dose manufacturing — Pharma Powder Dust Collection for granulation, tablet compression and film coating with cartridge or pulse-jet bag filter elements, GMP-cleanable housing, ATEX Zone 21/22 rating and IQ/OQ qualification documentation.
Technical Specifications
| Filter Type | Cartridge or pulse-jet bag — PTFE membrane |
| Efficiency | ≥99.9% at 1 µm particle size |
| OEB Rating | OEB 1–2 — non-potent compounds |
| ATEX | Zone 21/22 rated — Ex Cat 2/3 D |
| Material | 316L SS contact surfaces — GMP construction |
| Cleaning | Validated CIP or wet-wipe cleaning procedure |
Applications
OEB 3–4 HEPA Containment 🛡️
HEPA Safe-Change Contained Dust Collector
HEPA H14 Pharmaceutical Dust Filtration System with safe-change filter technology for moderate to high-potency compound handling — OEB 3–4 rated with double HEPA filtration, negative pressure operation, continuous pressure monitoring, safe-change bag-in/bag-out filter replacement and full containment leakage testing for IQ/OQ qualification.
Technical Specifications
| Filter | Double HEPA H14 — ≥99.995% at 0.3 µm |
| OEB Rating | OEB 3–4 — potent compound handling |
| Safe-Change | Bag-in/bag-out filter replacement — no operator exposure |
| Pressure | Negative pressure operation — inward leakage protection |
| Monitoring | HEPA filter integrity test port — DOP/DEHS test |
| ATEX | Zone 20/21 rated — Ex Cat 1/2 D |
Applications
OEB 5 Highly Potent ☣️
Highly Potent API Dust Collector — OEB 5
Maximum containment API Powder Dust Collection for OEB 5 highly potent compounds — cytotoxics, hormones and nanogram-OEL active ingredients. Triple HEPA filtration with validated containment testing, full enclosure with pressure cascade, glovebox-standard bag-out filter change, and containment performance verification as part of IQ/OQ qualification protocol.
Technical Specifications
| Filter | Triple HEPA H14 — maximum containment |
| OEB Rating | OEB 5 — OEL ≤0.1 µg/m³ (nanogram range) |
| Containment | Glovebox-standard bag-out filter change |
| Pressure | Negative pressure cascade — multiple barriers |
| Validation | Containment performance test with surrogate powder |
| Applications | Cytotoxics, oncology APIs, potent hormones |
Applications
Why Choose Domnick
Benefits of Our GMP Pharmaceutical Dust Collector Systems
A Pharmaceutical Manufacturing Dust Control system must satisfy GMP inspectors, occupational health regulators, ATEX authorities and production engineers simultaneously. We design dust collection systems that satisfy all four requirements from the specification stage.
01🎯
OEB-Classified Containment Specification
Pharma Dust Extraction System matched to compound OEB classification — OEB 1–2 cartridge filter, OEB 3–4 HEPA safe-change, OEB 5 triple-HEPA containment. Every system specified to the containment level the compound potency actually requires, with documented OEB-to-system justification for GMP inspection.
02🛡️
HEPA H14 — Safe-Change Filter Technology
HEPA H14 double filtration with bag-in/bag-out safe-change system ensures operators are never exposed to captured potent pharmaceutical powder during filter replacement — the single most critical occupational safety requirement for Pharmaceutical Powder Containment in potent compound manufacturing.
03💥
ATEX Certified — Zone 20/21/22
All systems ATEX-rated for the zone classification of the pharmaceutical processing area — from Zone 22 rated standard collectors for tablet compression to Zone 20 rated Ex Cat 1D systems for the inside of the collector housing, compliant with ATEX Directive 2014/34/EU and NFPA 652.
04📋
IQ/OQ Qualification Documentation
Containment performance testing using surrogate powder, HEPA integrity testing (DOP/DEHS), negative pressure verification, airflow testing and safe-change procedure qualification — all structured as IQ/OQ documentation aligned to your facility Validation Master Plan and GMP inspection requirements.
05🧹
GMP Cleanable Design
Smooth internal surfaces, no dead zones, tool-free disassembly and validated cleaning procedures — ensuring the Cleanroom Dust Collection System can be cleaned to health-based exposure limits between different product runs in multi-product pharmaceutical manufacturing facilities.
06📡
Continuous Monitoring & BMS Integration
Differential pressure monitoring across filter stages, airflow measurement, HEPA integrity port, negative pressure monitoring with BMS alarm relay — providing the continuous performance evidence that GMP and occupational health regulations require for validated containment systems.
Applications
Pharmaceutical Dust Collector Applications in GMP Manufacturing
Dust collection requirements vary significantly across pharmaceutical manufacturing operations — from high-volume granulation exhaust in non-potent solid dose manufacturing to nanogram-OEL cytotoxic compound handling. Each application requires a different containment level and filter specification.
💊
Granulation & Tablet Compression
Solid Dosage Manufacturing · OEB 1–3
Cartridge or pulse-jet Pharma Powder Dust Collection for wet/dry granulator exhaust, tablet press dust extraction and roller compactor powder containment — high airflow capacity required for granulation operations; ATEX Zone 21/22 mandatory for most OSD excipients and APIs; validated cleaning procedure required for multi-product facilities
EU GMP Part I · ATEX 2014/34/EU⚗️
API & Potent Compound Handling
HPAPI Manufacturing · OEB 3–5
HEPA safe-change API Powder Dust Collection for potent API dispensing, weighing, milling and transfer operations — containment performance testing with surrogate powder required before GMP use; negative pressure operation; bag-in/bag-out filter change; cytotoxic compound handling requires OEB 5 triple-HEPA with glovebox-standard containment
ICH Q3C · EMA HBEL Guidelines🔬
Milling & Micronisation
Particle Size Reduction · OEB 2–5
High-containment dust collector for pharmaceutical milling and micronisation operations — particle size reduction processes generate extremely fine airborne powder requiring ULPA or HEPA H14 filtration; enclosed mill with integral dust collection preferred for OEB 3+; ATEX Zone 20 inside collector housing for high-energy combustible particle generation environments
ICH Q6A · EU GMP Part II🏭
Cleanroom Powder Handling Areas
Cleanroom Manufacturing · Grade C/D
Cleanroom Dust Collection System for powder weighing and dispensing areas in Grade C/D cleanrooms — local exhaust ventilation at weighing booths and dispensing stations maintains operator OEL protection while dust-free recirculation maintains cleanroom particle classification; HEPA filtration prevents captured powder from contaminating cleanroom environment
ISO 14644 · EU GMP Annex 1🧪
Laboratory & R&D Sampling
Quality Control · Research
Compact HEPA dust collectors for pharmaceutical laboratory powder sampling, reference standard handling, dissolution sample preparation and small-scale synthesis — laboratory dust collectors must match the OEB of the compound being handled, with safe-change filter regardless of scale; regular containment verification required for high-potency compound laboratories
ICH Q2(R1) · facility spec📦
Filling & Packaging Operations
Primary Packaging · Solid Dose
Capsule filling machine and blister packaging line dust extraction — capturing powder dust generated during capsule filling, tablet blister sealing and powder product packaging; dust extraction prevents product cross-contamination of packaging materials and maintains area particulate counts within cleanroom classification limits; HEPA filtration required where exhausted to cleanroom
EU GMP Part I · ISO 14644 Containment & Technology Guide
OEB Classification, Filter Technology Selection & ATEX Zone Requirements for Pharmaceutical Dust Collectors
Selecting the correct Pharmaceutical Dust Collector requires three parallel decisions: what containment level does the compound's OEB classification require, what filter technology achieves that containment, and what ATEX zone rating does the processing area require? Getting any one of these wrong creates either an under-specified system that fails to protect operators, or an over-specified system that creates unnecessary capital cost. This guide covers all three decisions systematically.
Occupational Exposure Band (OEB) Classification — Containment Requirements for Pharmaceutical Dust Collectors
1 OEB 1
OEL >1 mg/m³
- Non-potent excipients & APIs
- Standard GMP dust collector
- Cartridge or bag filter
- Conventional filter change
- Lactose, microcrystalline cellulose
2 OEB 2
OEL 100 µg–1 mg/m³
- Low-potency APIs
- Enhanced GMP dust collector
- HEPA secondary filter
- PPE for filter change
- Most common analgesics
3 OEB 3
OEL 10–100 µg/m³
- Moderate potency APIs
- HEPA H14 dust collector
- Safe-change filter system
- Negative pressure operation
- Steroids, beta-blockers
4 OEB 4
OEL 0.1–10 µg/m³
- High-potency APIs (HPAPI)
- Double HEPA H14 + safe-change
- Containment performance test
- Bag-in/bag-out filter change
- Cytostatics, potent hormones
5 OEB 5
OEL ≤0.1 µg/m³
- Highly potent — cytotoxics
- Triple HEPA — maximum containment
- Glovebox-standard bag-out
- Pressure cascade — multi-barrier
- Oncology APIs, hormones
Filter Technology Selection — Pulse-Jet Bag, Cartridge & HEPA for Pharmaceutical Applications
The filter technology determines both the separation efficiency achieved and the containment level possible. In pharmaceutical dust collection, filter selection is driven by the compound's OEB classification — higher OEB compounds require higher filter efficiency and more stringent change-out procedures. Standard industrial filter technologies are only appropriate for OEB 1–2 compounds.
Technology A — OEB 1–2
Pulse-Jet Bag / Cartridge Filter
PTFE membrane bag or pleated cartridge element
How it works: Contaminated air drawn through pleated filter media; collected powder forms a filter cake on the upstream surface; periodic reverse-pulse jet of compressed air dislodges the cake into a collection hopper below. PTFE membrane coating prevents powder blinding and ensures efficient pulse-jet cleaning of sticky pharmaceutical powders.
Pharmaceutical use: Appropriate for OEB 1–2 compounds where conventional filter element change-out with PPE is an acceptable risk. High airflow capacity makes this technology the standard choice for granulation exhaust, tablet press extraction and film coating — all high-volume, non-potent solid dose applications. Not suitable for OEB 3+ without secondary HEPA containment filter.
OEB 1 ✓ OEB 2 ✓ OEB 3 ✗ OEB 4 ✗ OEB 5 ✗
Technology B — OEB 2–4
HEPA H14 Safe-Change Filter
H14 glass fibre HEPA with bag-in/bag-out housing
How it works: Contaminated air passes through a pre-filter stage (bulk powder removal) then through a HEPA H14 filter achieving ≥99.995% efficiency at the Most Penetrating Particle Size (MPPS) of 0.3 µm. The HEPA housing is designed for bag-in/bag-out filter replacement — a contained change-out sequence where the spent filter is sealed inside a protective bag before removal, preventing operator exposure to captured potent powder.
Pharmaceutical use: The standard technology for OEB 3–4 pharmaceutical dust collection — mandated by ISPE guidelines for potent compound handling areas. Negative pressure operation ensures that any housing leakage is inward rather than outward. DOP/DEHS aerosol challenge testing of each installed HEPA filter is required as part of IQ/OQ qualification.
OEB 1 ✓ OEB 2 ✓ OEB 3 ✓ OEB 4 ✓ OEB 5 ✗
Technology C — OEB 4–5
Triple HEPA / ULPA Contained System
ULPA U15 or triple HEPA H14 with pressure cascade
How it works: Maximum containment configuration using triple HEPA H14 stages in series or a single ULPA U15 element — providing 99.9995% or greater efficiency at the ULPA Most Penetrating Particle Size of 0.12 µm. Multiple containment barriers with negative pressure cascade ensure that no pathway exists for captured cytotoxic compounds to reach the operator environment. Filter change-out uses glovebox-standard continuous liner bag with complete enclosure of the spent filter before any seal is broken.
Pharmaceutical use: Required for OEB 5 cytotoxic compound handling — oncology APIs, potent hormones and any compound with an OEL at or below 0.1 µg/m³. Containment performance validation using surrogate challenge powder and personal air sampling is required as part of IQ/OQ qualification, with results compared to OEL-derived acceptance criteria specific to the compound being handled.
OEB 1 ✓ OEB 2 ✓ OEB 3 ✓ OEB 4 ✓ OEB 5 ✓
ATEX Dust Hazard Zone Classification for Pharmaceutical Manufacturing Areas
ATEX Directive 2014/34/EU and national equivalents require pharmaceutical manufacturers to classify all areas where combustible dust is handled or stored as dust explosion hazard zones — and to specify dust collection equipment certified for the zone in which it operates. The zone classification for pharmaceutical manufacturing depends on the frequency and duration of explosive dust cloud formation. Equipment inside the dust collector housing is classified separately from the surrounding processing area.
| Zone | Definition | Typical Pharma Location | Equipment Category Required | Pharmaceutical Examples |
|---|---|---|---|---|
| Zone 20 | ZONE 20 — Area where explosive dust cloud is continuously present or present for long periods | Inside the dust collector housing; inside silos, hoppers and pneumatic conveying pipes during operation | Ex Category 1D — very high protection level (EPL Da). Provides two independent protection means. | Interior of pharmaceutical dust collector vessel during operation; inside powder storage silos for API/excipient |
| Zone 21 | ZONE 21 — Area where explosive dust cloud is likely to occur in normal operation occasionally | Immediate vicinity of charging ports, transfer connections, dust collector inlets and pharmaceutical powder handling points | Ex Category 2D — high protection level (EPL Db). Provides protection even if one protection means fails. | Tablet press dust extraction hood; granulator powder outlet; dispensing booth; bag dump station |
| Zone 22 | ZONE 22 — Area where explosive dust cloud is unlikely but may occur for a short period in abnormal conditions | General pharmaceutical processing area surrounding powder handling operations; tablet press area; granulation room | Ex Category 3D — normal protection level (EPL Dc). Provides protection in normal operation. | General tablet compression area; granulation suite; capsule filling room; powder packaging hall |
| Non-Hazardous | No explosive dust cloud risk under any conditions — dust is non-combustible or completely absent | Administrative areas, control rooms, cleanrooms where only pre-packaged product handled; fluid-path-only pharmaceutical processing | Standard non-ATEX equipment acceptable — no special certification required | Quality control laboratory (solution analysis only); visual inspection area; tablet coating (aqueous process, below LEL) |
Standards & Compliance
EU GMP Chapters 3 & 5 ATEX 2014/34/EU HEPA EN 1822 H14 ISPE Containment Guide EMA HBEL Guidelines ISO 14644 NFPA 652 ICH Q9
Specify Your OEB-Classified Pharmaceutical Dust Collector
Our pharmaceutical containment engineers design complete dust collection systems for pharmaceutical manufacturers throughout Thailand. From OEB classification and ATEX zone assessment to filter technology selection, HEPA safe-change system design, containment performance testing, and IQ/OQ qualification documentation, we deliver reliable dust control solutions for regulated pharmaceutical manufacturing environments.
Get expert guidance when you need it. Our support team is here to provide you with the right solutions.
